FDBusiness.com

New whey protein set to shake up clinical nutrition market.

 Breaking News
  • Ardgowan Unveils Plans For Inverclyde Distillery Ardgowan Distillery has revealed ambitious designs for its new £12 million distillery which is being built on the Ardgowan Estate near Inverkip, 30 miles west of Glasgow. The plans showcase the flagship building which has just secured revised planning consent from Inverclyde Council. The striking new design, by Michael Laird Architects, brings a number of improvements [...]...
  • HKScan Launches Exports of Finnish Poultry Products to Sweden HKScan, the Nordic food and meat group, has started exporting Finnish poultry products to Sweden. They will initially be sold through the largest retailer ICA’s outlets under the Karinäs®(Kariniemen®) brand. The launch gives Swedish consumers access to a new innovation: high welfare farm-born poultry that is hatched on the farm where it is raised. This new concept is [...]...
  • Almonds Retain Top Spot For Nut Introductions in Europe According to Innova Market Research’s latest Global New Product Introductions Report, almonds retain the number one spot for nut introductions in Europe. With a 47% share of global almond product introductions, the region leads globally for the eleventh year running. Europe as a whole saw a total of 5,017 new introductions with almonds – a [...]...
  • Arla Foods UK Launches New Standards Model to Bring Sustainable Change to Dairy Farming With ongoing volatility in the global milk markets, increasing consumer misunderstanding of the sector, polarised levels of support for UK dairy farmers and a new post-Brexit Agriculture Bill the challenges for dairy farmers are mounting. Farmer-owned co-operative Arla Foods has launched ‘Arla UK 360’ – a new standard in UK dairy farming. The Arla UK 360 [...]...
  • €172 Million to Promote EU Agri-food Products In and Outside the EU The European Commission will provide funding of €172.5 million from the EU agricultural budget to promote EU agri-food products in Europe and across the world. 79 campaigns, covering a wide range of products such as dairy products, olives and olive oil, and fruit and vegetables, will be rolled out over the next three years. Agriculture and [...]...

New whey protein set to shake up clinical nutrition market.

August 31
11:50 2012

A ground-breaking whey protein is set to transform the fast-growing clinical nutrition category by offering companies the opportunity to create a 100% whey-based ready-to-drink beverage that is more effective, easier to formulate and better-tasting.

 Lacprodan® DI-7017 from Arla Foods Ingredients is a new generation of pure whey protein concentrate that is stable in ultra-high temperature (UHT) formulations at neutral pH, representing a genuine first in the market for clinical nutrition RTD beverages, which was worth almost €4 billion in the US & Europe in 2011.

 Whey protein is notoriously hard to incorporate into UHT processes, which are widely used to manufacture clinical nutrition beverages with a long shelf life. As a result, manufacturers have until now tended to use alternative and less nutritionally effective proteins, such as casein, when formulating beverages for use in clinical nutrition. Such beverages are consumed primarily by elderly people suffering with conditions such as sarcopenia (muscle wastage) and patients recovering from illness or surgery.

 However, incorporating whey protein into clinical nutrition beverages is highly desirable because there is compelling scientific evidence that whey delivers faster ‘gastric emptying’ and greater levels of muscle synthesis than other protein ingredients.

 Now Arla Foods Ingredients’ scientists have overcome the technical challenges associated with a producing a 100% whey protein concentrate ingredient that is stable when subjected to UHT processing to create Lacprodan® DI-7017 – and the company is confident the innovative ingredient will generate huge levels of excitement in the clinical nutrition arena.

 Peter Schouw Andersen, Business Development Manager at Arla Foods Ingredients, said: “Clinical nutrition represents a huge opportunity for food and beverage manufacturers. According to a recent Business Insights report[1], the market for RTD beverages for use in the clinical nutrition environment was worth €2 billion in US and €1.6 billion in Europe in 2011 alone. Meanwhile, the total number of clinical nutrition patients is expected grow by more than 7% a year between now and 2015, primarily because of the world’s ageing population.”

 He continued: “However, for technical reasons, manufacturers have been seriously undermined by their inability to formulate clinical nutrition beverages with pure whey protein concentrate. Now, with the launch of Lacprodan® DI-7017, that is all set to change for the better.”

 The benefits of whey protein over other sources of protein are well documented in the scientific literature, with studies demonstrating that whey protein passes through the gut more quickly than casein[2],[3] leading to faster gastric emptying and absorption of the protein. Whey also offers roughly twice the levels of muscle synthesis as casein[4]. Meanwhile, the amino acid profile in whey proteins covers or even exceeds the human requirements for essential amino acids, according to standards set by the World Health Organisation.

Available in powder form, Lacprodan® DI-7017 is suitable for use in both pH acid and pH neutral formulations, increasing the variety of product types and packaging formats into which it can be incorporated. It is suitable in the milky beverages typically used in clinical nutrition, but can also be incorporated into less viscous beverages which may be easier for some patients to drink.

 Peter Schouw Andersen said: “The need for effective RTD beverages that offer high performance clinical nutrition has never been greater. All over the developed world, people are living longer lives. In the European Union, for instance, average life expectancy is forecast to reach 89 years for women and 84.5 years for men by 2060. This is a highly positive trend, but one side-effect is that that protein malnutrition is an increasingly common problem. In fact, up to 60% of elderly hospital patients suffer from the condition, according to the British Dietetic Association.”

 He added: “Taken together, the scientific evidence points overwhelmingly to the fact that people drinking Lacprodan® DI-7017 will experience faster recovery from illness. With the world’s ageing population placing a strain on medical and social care services, there’s no doubt that this highly effective UHT-stable whey protein concentrate can play a key role in maintaining high standards of clinical nutrition and care.

 

About Author

colin

colin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • October 18, 2018Future Food-Tech London - Marketing Partnership
  • October 21, 2018Int'l Food Products Exhibition (Sial)
  • October 25, 2018Italian Espresso Coffee Show (TriestEspresso Expo)
  • October 25, 2018Finnish Food Fair
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements